0001683168-21-004018.txt : 20210831
0001683168-21-004018.hdr.sgml : 20210831
20210831182335
ACCESSION NUMBER: 0001683168-21-004018
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210810
FILED AS OF DATE: 20210831
DATE AS OF CHANGE: 20210831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crabtree Gerald W
CENTRAL INDEX KEY: 0001564239
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40699
FILM NUMBER: 211228155
MAIL ADDRESS:
STREET 1: 12510 PROSPERITY DR.
STREET 2: SUITE #310
CITY: SILVER SPRING
STATE: MD
ZIP: 20904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc.
CENTRAL INDEX KEY: 0001157075
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621772151
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
BUSINESS PHONE: (917) 595.2850
MAIL ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
FORMER COMPANY:
FORMER CONFORMED NAME: NUVILEX, INC.
DATE OF NAME CHANGE: 20090324
FORMER COMPANY:
FORMER CONFORMED NAME: EFOODSAFETY COM INC
DATE OF NAME CHANGE: 20010808
3
1
ownership.xml
X0206
3
2021-08-10
0
0001157075
PharmaCyte Biotech, Inc.
PMCB
0001564239
Crabtree Gerald W
23046 AVENIDA DE LA CARLOTA
SUITE 600
LAGUNA HILLS
CA
92653
1
1
0
0
Chief Science Officer
Common Stock
11200
D
Stock Option (right to buy)
156.00
2017-03-09
2022-03-09
Common Stock
1000
D
Stock Option (right to buy)
83.70
2018-01-01
2023-01-01
Common Stock
1000
D
Stock Option (right to buy)
74.25
2019-03-20
2024-03-20
Common Stock
1000
D
Stock Option (right to buy)
61.20
2020-01-02
2025-01-01
Common Stock
1000
D
Stock Option (right to buy)
10.05
2021-01-01
2025-12-31
Common Stock
1000
D
The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021 (the "Reverse Split").
The exercise price has been adjusted to reflect the Reverse Split.
The option vested in twelve equal monthly installments beginning on January 1, 2021.
/s/ Gerald W. Crabtree
2021-08-31